A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

NCT03645330 · clinicaltrials.gov ↗

COMPLETED

Status

1026

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small-Cell Lung Cancer

Sponsor

Chugai Pharmaceutical

Collaborators

[object Object]